Every Form 4 that Medpace Holdings, Inc. (MEDP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MEDP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MEDP filings page.
Medpace Holdings (MEDP): Form 4 insider transaction — On 10/27/2025, General Counsel & Corp. Secy. Stephen P. Ewald exercised 18,230 employee stock options at $166.73 and sold 15,230 shares of common stock at a weighted average price of $598.85 (transactions ranged from $596.25 to $602.955). Following these transactions, he beneficially owned 13,343 shares directly. The option was reported to have vested in full on October 27, 2025, and the derivative position was reduced to 0; the option carried an expiration date of 10/27/2026.
Medpace Holdings (MEDP): insider transaction — An executive officer sold common stock. On 10/27/2025, the Executive Vice President, Operations sold 2,000 shares in an open market transaction at a weighted average price of $605.01, with individual trades ranging from $605.00 to $605.13. The sale was executed via a limit order during an open window period. Following the sale, the officer beneficially owns 65,500 shares, held directly.
Robert O. Kraft, a director of Medpace Holdings, Inc. (MEDP), reported a securities transaction on 09/30/2025. The filing shows 57 restricted stock units vested and were reported as delivered, arising from a 227-unit grant made on 11/29/2024 that vests in four approximately equal installments on 03/31/2025, 06/30/2025, 09/30/2025 and 12/31/2025. Each restricted stock unit represents the right to receive one share of MEDP common stock. After the reported transaction the form lists 833 shares of common stock beneficially owned by the reporting person.
Cornelius P. McCarthy III, a director of Medpace Holdings, Inc. (MEDP), reported a vesting-related transaction dated 09/30/2025. 49 restricted stock units converted into 49 shares of common stock at $0 consideration, and the report shows the reporting person beneficially owns 10,246 shares following the transaction. The restricted stock units stem from a grant of 198 RSUs on 11/29/2024 that vest in four approximately equal installments on 3/31/2025, 6/30/2025, 9/30/2025, and 12/31/2025.
This Form 4 indicates a routine vesting event rather than an open-market purchase or sale; the transaction code is reported as "M" for vesting. The filing was signed by an attorney-in-fact on behalf of the reporting person.
Susan E. Burwig, Executive Vice President, Operations at Medpace Holdings, Inc. (MEDP), exercised employee stock options to acquire 10,000 shares on 09/26/2025 at an exercise price of $107.93 per share. The filing states the option vested in full on 02/28/2020. The Form 4 lists 67,500 shares as the amount of common stock beneficially owned following the non-derivative transaction and lists 30,984 shares as the number of derivative securities beneficially owned following the derivative transaction. The form is signed by an attorney-in-fact on behalf of Ms. Burwig on 09/30/2025.